?

Neurology Market Research Reports & Industry Analysis

The notion “neurology” refers to a branch of medical scientific study dealing with central, peripheral and autonomic nervous systems, and their structure, functions and disorders, in particular. Companies involved in the neurology market produce a wide range of neurology devices. Neurology devices represent the largest and the most promising segments of the medical devices market.

In late 2016, the worldwide neurology devices market is expected to be over USD 7 billion. The largest neurology devices market is the USA, followed by Japan. Boston Scientific Corporation, DePuy Inc., CareFusion Corporation, Accuracy Inc. are amid major industry participants.

Research reports available in the Catalogue include data on the neurology devices market. The reports provide the profiles of the key vendors in the market space; analyses of trends factors affecting the market and forces contributing to the industry growth. The research studies evaluate the competitive landscape and future industry projections.

Found 51 publications
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis US$ 10,995.00

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The ... newer epilepsy drugs into the Asian market, particularly in Japan. Government cost-cutting measures will negatively impact epilepsy drug market in the EU Scope Overview of epilepsy ...

Jan, 2013 271 pages
Japanese Marktet for Neurovascular Devices US$ 6,995.00

... at nearly $553 million. The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, ... in this market will be driven by the rapidly growing aging population in Japan and the increased demand and acceptance of endovascular cerebral aneurysm ...

Nov, 2013 76 pages
Chinese Market for Neurological Devices US$ 6,995.00

... was valued at over $528 million. The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF ... -based stereotactic systems, frameless stereotactic systems and aneurysm clips. Market growth will be driven by the continued acceptance of aneurysm treatment procedures, ...

Nov, 2013 242 pages
EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022 US$ 3,995.00

... , making stroke a major burden for the affected individual and the entire healthcare system in each country. Scope The Acute Ischemic Stroke (AIS) EpiCast Report provides ... cases of AIS. The AIS epidemiology report is written and developed by Masters and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent ...

Sep, 2013 86 pages
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it? US$ 695.00

... Sanofi securing European approval for its multiple sclerosis ... therapies (Gilenya, Aubagio and Tecfidera – yet to launch in Europe) providing comparable efficacy with greater convenience, there is ... patients using the drug developing PML. This week's Physician Views poll will ask neurologists based in the 5EU ( ...

Sep, 2013
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU US$ 695.00

... collectively as the ABCRs), which for many years were positioned as the gold standard therapies of choice - see Physician Views Poll Results – Neurologists ... analysts, which Novartis and Sanofi will no doubt do their best to rectify. Analysts at Barclays recently noted that 'importantly, the multiple sclerosis ...

Sep, 2013
The Top 50 Neurodevice Companies Worldwide US$ 464.00

... , Number of Employees, Turnover and Foreign Trade. Report Target Market: 1) Neurodevice Companies Usage: competitive/financial analysis and strategic partner/alliance ... your business. Learn more about your target markets and target companies Top level research on all the major players in a market See ...

May, 2012 97 pages
The Top 30 Neurology Contract Research Organisations In Western Europe US$ 280.00

... 's Disease and Multiple Sclerosis. They are located right across Europe, from Belgium and the Netherlands to Sweden and Denmark. Profile ... , Biotechnology and Medical Device Associations The Top 30 Neurology Contract Research Organisations In Western Europe is a useful reference tool for CRO, pharmaceutical, ...

Aug, 2013 91 pages
Global Neurovascular Market: Trends & Opportunities (2013-18) US$ 800.00

... (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the ... sphere. The report primarily focuses on the two chief segments of neurovascular disorder: hemorrhagic stroke and ischemic stroke. The report further ...

Jul, 2013 46 pages
Indian Neurological Devices Market US$ 5,995.00

In 2012, the Indian market for neurological devices was valued at $13.5 million. The Indian market for neurological devices includes detachable coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, neuromodulation systems, neuroendoscopes, stereotactic systems and ...

Aug, 2013 236 pages
Neurostimulation Devices Market, 2012-2017 US$ 1,699.00

... continue to be the largest segment in the neurostimulation devices market over the forecast period (2012 to 2017). 3. Deep Brain Stimulation (DBS) segment ... companies. It also contains a SWOT analysis and detailed profile of leading devices within this segment. We have looked at both the existing commercial ...

Nov, 2012 124 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H1 2015 US$ 2,000.00

... Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H1 2015’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing ...

Feb, 2015 74 pages
Neuropathy – Pipeline Review, H1 2013 US$ 2,000.00

Neuropathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuropathy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development ... -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built using data and ...

Apr, 2013 77 pages
Essential Tremor – Pipeline Review, H1 2013 US$ 2,000.00

Essential Tremor – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Essential Tremor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development ... -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ...

Apr, 2013 32 pages
Global Deep Brain Stimulator Market 2012-2016 US$ 2,000.00 US$ 1,600.00

... key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the ... of deep brain stimulation treatment could pose a challenge to the growth of this market. TechNavio's report, Global Deep Brain Stimulator Market 2012-2016, has been prepared based on an in-depth market analysis of the market ...

Apr, 2013 37 pages
Global Neurostimulation Devices Market 2015 US$ 2,500.00

... market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others. Technavio's report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts ...

Jun, 2015 83 pages
Intraoperative Neuromonitoring Market in the US 2015-2019 US$ 2,500.00 US$ 2,000.00

... and the growth prospects of the Intraoperative Neuromonitoring market in the US for the period 2014-2019. To calculate the market size, the report considers the ... , the Intraoperative Neuromonitoring Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Intraoperative Neuromonitoring market in the ...

Nov, 2014 89 pages
European Neurological Device Markets US$ 8,995.00

In 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of ... hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that ...

Mar, 2013 410 pages
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022'. Epilepsy ... the changing competitive landscape for Epilepsy Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022'. Epilepsy ... the changing competitive landscape for Epilepsy Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022'. Epilepsy ... of Epilepsy including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on the key drugs in Spain ...

Feb, 2013 129 pages
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022'. Epilepsy ... in Japan compared with other countries. Government regulations on drug approval and pricing, however, limit or delay drug entry and profitability Japan. SCOPE Overview of Epilepsy including ...

Feb, 2013 135 pages
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022'. Epilepsy ... of Epilepsy including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on the key drugs in Italy ...

Feb, 2013 132 pages
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022'. Epilepsy ... increased epilepsy treatment in the whole population. However, loose government regulation of patent protection severely impacts brand drug profitability in India. SCOPE Overview of Epilepsy including ...

Feb, 2013 128 pages
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022'. Epilepsy ... of Epilepsy including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on the key drugs in Germany ...

Feb, 2013 136 pages
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022'. Epilepsy ... of Epilepsy including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on the key drugs in France ...

Feb, 2013 130 pages
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 US$ 4,995.00

PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022'. Epilepsy ... the top drugs in China from 2012-2022. Analysis of the impact of key events as well the drivers and restraints affecting China Epilepsy market. REASONS ...

Feb, 2013 114 pages
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2023 US$ 3,995.00

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2023 Summary AD is an irreversible, neurodegenerative brain disease of the elderly, which leads to a progressive decline in memory and cognitive ... to 108.41 million cases in 2013 at a decadal growth rate of 31.80%. Scope The Alzheimer’s disease (AD) EpiCast Report provides an overview of the risk factors and global trends of AD in the ...

Mar, 2015 82 pages
Global Neurovascular Intervention Devices Market 2011-2015 US$ 1,500.00 US$ 1,200.00

... disorders. The Global Neurovascular Intervention Devices market has also been witnessing the trend of an increase in mergers and acquisitions. However, the high cost of neurovascular intervention treatment could pose a challenge to the growth of this market. TechNavio's report, the Global Neurovascular Intervention Devices Market 2011-2015, has been prepared based on an in-depth market analysis ...

Nov, 2012 44 pages
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends &... US$ 4,650.00 US$ 4,185.00

... aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). The neurointerventional devices market ... . Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital ...

Oct, 2012 234 pages
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014 US$ 2,000.00

... Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing ...

Oct, 2014 73 pages
Neuropathy - Pipeline Review, H2 2013 US$ 2,000.00

... therapeutic development for Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review ...

Oct, 2013 36 pages
Essential Tremor – Pipeline Review, H2 2012 US$ 2,000.00

Essential Tremor – Pipeline Review, H2 2012 SUMMARY Global Markets Direct’s, 'Essential Tremor - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development ... -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ...

Oct, 2012 37 pages
Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth US$ 3,500.00

Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth Summary GBI Research’s report, “Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth ...

Jul, 2011 118 pages
United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the United Arab Emirates Neurology Devices market ...

May, 2012 109 pages
Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Turkey Neurology Devices market. The ...

May, 2012 106 pages
Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Switzerland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Switzerland Neurology Devices market. The ...

May, 2012 108 pages
Portugal Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Portugal Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Portugal Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Portugal Neurology Devices market. The ...

May, 2012 99 pages
Poland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Poland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Poland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Poland Neurology Devices market. The ...

May, 2012 105 pages
Norway Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Norway Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Norway Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Norway Neurology Devices market. The ...

May, 2012 96 pages
Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Ireland Neurology Devices market. The ...

May, 2012 99 pages
Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Hungary Neurology Devices market. The ...

May, 2012 98 pages
Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Greece Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Greece Neurology Devices market. The ...

May, 2012 103 pages
Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Finland Neurology Devices market. The ...

May, 2012 98 pages
Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Egypt Neurology Devices market. The ...

May, 2012 98 pages
Chile Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 US$ 2,500.00

Chile Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary ”Chile Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile Neurology Devices market. The ...

May, 2012 105 pages
European Markets for Neurological Devices 2010 (15 Countries) US$ 11,495.00

... devices. This market includes: Cerebrospinal fluid (CSF) shunts CSF drainage systems Detachable coils Liquid embolics Neurovascular catheters Neurovascular guidewires Neurovascular stents Spinal cord stimulators Vagus nerve stimulators Deep brain stimulators Sacral nerve stimulators ...

Jun, 2010 369 pages
European Markets for Neurological Devices 2010 (15 Countries) (Executive Summary) US$ 195.00

In 2009, the European market for neurological devices was valued at almost €500 million. This report covers Austria, Benelux, France, Germany, Italy, ... as Boston Scientific, Carl Zeiss, Codman, Medtronic and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis ...

Jun, 2010 12 pages
U.S. Market for Neurological Devices US$ 5,995.00

In 2011, the U.S. neurological device market was valued at over $2.7 billion. This market encompasses CSF shunts, CSF external drainage systems, intracranial pressure ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...

Mar, 2013 396 pages
The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis US$ 3,500.00

... and analysis on the global neurology devices market, a key segment within the medical device industry. This medical device report provides market landscape, competitive ... and market trends information on five neurology devices market categories - CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery. The report provides ...

Feb, 2010 74 pages
1 2 >
Skip to top